Abstract
Over the past 5 years, the advent of echocardiographic screening for rheumatic heart disease (RHD) has revealed a higher RHD burden than previously thought. In light of this global experience, the development of new international echocardiographic guidelines that address the full spectrum of the rheumatic disease process is opportune. Systematic differences in the reporting of and diagnostic approach to RHD exist, reflecting differences in local experience and disease patterns. The World Heart Federation echocardiographic criteria for RHD have, therefore, been developed and are formulated on the basis of the best available evidence. Three categories are defined on the basis of assessment by 2D, continuous-wave, and color-Doppler echocardiography: 'definite RHD', 'borderline RHD', and 'normal'. Four subcategories of 'definite RHD' and three subcategories of 'borderline RHD' exist, to reflect the various disease patterns. The morphological features of RHD and the criteria for pathological mitral and aortic regurgitation are also defined. The criteria are modified for those aged over 20 years on the basis of the available evidence. The standardized criteria aim to permit rapid and consistent identification of individuals with RHD without a clear history of acute rheumatic fever and hence allow enrollment into secondary prophylaxis programs. However, important unanswered questions remain about the importance of subclinical disease (borderline or definite RHD on echocardiography without a clinical pathological murmur), and about the practicalities of implementing screening programs. These standardized criteria will help enable new studies to be designed to evaluate the role of echocardiographic screening in RHD control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
192,54 € per year
only 16,05 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005).
Special Writing Group of the Committee on Rheumatic Fever and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. JAMA 268, 2069–2073 (1992).
World Health Organisation. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation, Geneva, 29 October–1 November 2001. WHO [online] (2010).
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia—an evidence-based review. Heart Foundation [online] (2006).
Heart Foundation of New Zealand and Cardiac Society of Australia and New Zealand. New Zealand guidelines for rheumatic fever 1: diagnosis, management and secondary prevention. Heart Foundation [online] (2006).
Feinstein, A. R. et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. vi. Clinical features of streptococcal infections and rheumatic recurrences. Ann. Intern. Med. 60 (Suppl. 5), 68–86 (1964).
Tompkins, D. G., Boxerbaum, B. & Liebman, J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45, 543–551 (1972).
Kassem, A. S., el-Walili, T. M., Zaher, S. R. & Ayman, M. Reversibility of mitral regurgitation following rheumatic fever: Clinical profile and echocardiographic evaluation. Indian J. Pediatr. 62, 717–723 (1995).
Milliken, A. The short term morbidity of acute rheumatic fever in children and youth under the age of 20 years at first diagnosis in Auckland, 1998–1999 (The University of Auckland, Auckland, 2003).
Talbot, R. G. Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxis. N. Z. Med. J. 97, 634–637 (1984).
Abbasi, A. S., Hashmi, J. A., Robinson, R. D. Jr., Suraya, S. & Syed, S. A. Prevalence of heart disease in school children of Karachi. Am. J. Cardiol. 18, 544–547 (1966).
Maharaj, B. et al. Screening for rheumatic heart disease amongst black school children in Inanda, South Africa. J. Trop. Pediatr. 33, 60–61 (1987).
Kumar, P., Garhwal, S. & Chaudhary, V. Rheumatic heart disease: a school survey in a rural area of Rajasthan. Indian Heart J. 44, 245–246 (1992).
Steer, A. C., Adams, J., Carlin, J., Nolan, T. & Shann, F. Rheumatic heart disease in school children in Samoa. Arch. Dis. Child. 81, 372 (1999).
Steer, A. C. et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J. Heart Valve Dis. 18, 327–335 (2009).
Marijon, E. et al. Rheumatic heart disease screening by echocardiography: The inadequacy of world health organization criteria for optimizing the diagnosis of subclinical disease. Circulation 120, 663–668 (2009).
Carapetis, J. R. et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 5, 411–417 (2008).
Paar, J. A. et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am. J. Cardiol. 105, 1809–1814 (2010).
Webb, R. H. et al. Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiol. Young 21, 436–443 (2011).
Reeves, B. M., Kado, J. & Brook, M. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J. Paediatr. Child Health 47, 473–478 (2011).
Bhaya, M., Panwar, S., Beniwal, R. & Panwar, R. B. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography 27, 448–453 (2010).
Marijon, E. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470–476 (2007).
Carapetis, J., Parr, J. & Cherian, T. Standardization of epidemiologic protocols for surveillance of post-streptococcal sequelae: acute rheumatic fever, rheumatic heart disease and acute post-streptococcal glomerulonephritis. Department of Health and Human Services, National Institutes of Health [online] (2010).
Nair, R., Aggarwal, R. & Khanna, D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin. Arthritis Rheum. 41, 95–105 (2011).
Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developer's handbook. Scottish Intercollegiate Guidelines Network [online] (2011).
Jaine, R., Baker, M. & Venugopal, K. Epidemiology of acute rheumatic fever in New Zealand 1996–2005. J. Paediatr. Child Health 44, 564–571 (2008).
Spinetto, H., Lennon, D. & Horsburgh, M. Rheumatic fever recurrence prevention: a nurse led programme of 28 day penicillin in an area of high endemnicity. J. Paediatr. Child Health 47, 228–234 (2011).
Jaine, R., Baker, M. & Venugopal, K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr. Infect. Dis. J. 30, 315–319 (2011).
Longo-Mbenza, B. et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int. J. Cardiol. 63, 287–294 (1998).
Sultan, F. A. et al. Rheumatic tricuspid valve disease: an evidence-based systematic overview. J. Heart Valve Dis. 19, 374–382 (2010).
Alkhalifa, M. S., Ibrahim, S. A. & Osman, S. H. Pattern and severity of rheumatic valvular lesions in children in Khartoum, Sudan. East. Mediterr. Health J. 14, 1015–1021 (2007).
Saleh, H. K. Pattern of rheumatic heart disease in Southern Yemen. Saudi Med. J. 28, 108–113 (2007).
Aurakzai, H. A. et al. Echocardiographic profile of rheumatic heart disease at a tertiary cardiac centre. J. Ayub Med. Coll. Abbottabad. 21, 122–126 (2009).
Marcus, R. H., Sareli, P., Pocock, W. A. & Barlow, J. B. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathological findings, and hemodynamic sequelae. Ann. Intern. Med. 120, 177–183 (1994).
Vasan, R. S. et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 94, 73–82 (1996).
Yuko-Jowi, C. & Bakari, M. Echocardiographic patterns of juvenile rheumatic heart disease at the Kenyatta National Hospital, Nairobi. East Afr. Med. J. 82, 514–519 (2005).
Lembo, N. J. et al. Mitral valve prolapse in patients with prior rheumatic fever. Circulation. 77, 830–836 (1988).
Atalay, S., Ucar, T., Ozcelik, N., Ekici, F. & Tutar, E. Echocardiographic evaluation of mitral valve in patients with pure rheumatic mitral regurgitation. Turk. J. Pediatr. 49, 148–153 (2007).
Vijayalakshmi, I. B., Vishnuprabhu, R. O., Chitra, N., Rajasri, R. & Anuradha, T. V. The efficacy of echocardiographic criterions for the diagnosis of carditis in acute rheumatic fever. Cardiol. Young 18, 586–592 (2008).
Camara, E. J., Neubauer, C., Camara, G. F. & Lopes, A. A. Mechanisms of mitral valvar insufficiency in children and adolescents with severe rheumatic heart disease: an echocardiographic study with clinical and epidemiological correlations. Cardiol. Young 14, 527–532 (2004).
Kalangos, A. et al. Anterior mitral leaflet prolapse as a primary cause of pure rheumatic mitral insufficiency. Ann. Thorac. Surg. 69, 755–761 (2000).
Chauvaud, S. et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 104 (12 Suppl. 1), I12–I15 (2001).
Skoularigis, J., Sinovich, V., Joubert, G. & Sareli, P. Evaluation of the long-term results of mitral valve repair in 254 young patients with rheumatic mitral regurgitation. Circulation 90 (5 Pt 2), II167–II174 (1994).
Tomaru, T. et al. Postinflammatory mitral and aortic valve prolapse: a clinical and pathological study. Circulation 76, 68–76 (1987).
Ungar, H. & Ben-Ishay, Z. Rheumatic and age changes of the heart in Israel: pathological and statistical study. Isr. J. Med. Sci. 1, 50–61 (1965).
van der Bel-Kahn, J. & Becker, A. E. The surgical pathology of rheumatic and floppy mitral valves. Distinctive morphologic features upon gross examination. Am. J. Surg. Pathol. 10, 282–292 (1986).
Feigenbaum, H., Armstrong, W. F. & Ryan, T. (Eds) Feigenbaum's Echocardiography, 6th edn Vol. 1 (Lippincott Williams & Wilkins, Philadelphia, 2005).
Waller, B. F., Howard, J. & Fess, S. Pathology of mitral valve stenosis and pure mitral regurgitation—Part I. Clin. Cardiol. 17, 330–336 (1994).
Iung, B. et al. Valvular heart disease in the community: a European experience. Curr. Prob. Cardiol. 32, 609–661 (2007).
Olson, L. J., Subramanian, R., Ackermann, D. M., Orszulak, T. A. & Edwards, W. D. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin. Proc. 62, 22–34 (1984).
Ratnakar, K. S., Rajagopal, P. & Somaraju, B. Surgical pathology of mitral valves—the Indian scene. Int. J. Cardiol. 24, 124–126 (1989).
Wilkins, G. T., Weyman, A. E., Abascal, V. M., Block, P. C. & Palacios, I. F. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br. Heart J. 60, 299–308 (1988).
Moore, P. et al. Valvular heart disease: severe congenital mitral stenosis in infants. Circulation 89, 2099–2106 (1994).
McElhinney, D. B. et al. Current management of severe congenital mitral stenosis: outcomes of transcatheter and surgical therapy in 108 infants and children. Circulation 112, 707–714 (2005).
Serraf, A. et al. Congenital mitral stenosis with or without associated defects: an evolving surgical strategy. Circulation 102 (19 Suppl. 3), III166–III171 (2000).
Selamet Tierney, E. S. et al. Echocardiographic predictors of mitral stenosis-related death or intervention in infants. Am. Heart J. 156, 384–390 (2008).
Akram, M. R., Chan, T., McAuliffe, S. & Chenzbraun, A. Non-rheumatic annular mitral stenosis: prevalence and characteristics. Eur. J. Echocardiogr. 10, 103–105 (2009).
Chockalingam, A., Gnanavelu, G., Elangovan, S. & Chockalingam, V. Clinical spectrum of chronic rheumatic heart disease in India. J. Heart Valve Dis. 12, 577–581 (2003).
Tantchou Tchoumi, J. C. & Butera, G. Rheumatic valvulopathies occurence, pattern and follow-up in rural area: the experience of the Shisong Hospital, Cameroon. Bull. Soc. Pathol. Exot. 102, 155–158 (2009).
Essien, I. O. et al. One year echocardiographic study of rheumatic heart disease at Enugu, Nigeria. Niger. Postgrad. Med. J. 15, 175–178 (2008).
Sani, M. U., Karaye, K. M. & Borodo, M. M. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc. J. Afr. 18, 295–299 (2007).
Deshpande, J., Vaideeswar, P., Amonkar, G. & Vasandani, S. Rheumatic heart disease in the past decade: an autopsy analysis. Ind. Heart J. 54, 676–680 (2002).
Ozer, O., Davutoglu, V., Sari, I., Akkoyun, D. C. & Sucu, M. The spectrum of rheumatic heart disease in the southeastern Anatolia endemic region: results from 1900 patients. J. Heart Valve Dis. 18, 68–72 (2009).
Clawson, B. J. Rheumatic heart disease. An analysis of 796 cases. Am. Heart J. 20, 454–474 (1940).
Ba-Saddik, I. A. et al. Prevalence of rheumatic heart disease among school-children in Aden, Yemen. Ann. Trop. Paediatr. 31, 37–46 (2011).
Ravisha, M. S., Tullu, M. S. & Kamat, J. R. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch. Med. Res. 34, 382–387 (2003).
Dawber, T. R. & Stokes, J. 3rd. Rheumatic heart disease in the Framingham study. N. Engl. J. Med. 255, 1228–1233 (1956).
Veasy, L. G., Tani, L. Y. & Hill, H. R. Persistence of acute rheumatic fever in the intermountain area of the United States. J. Pediatr. 124, 9–16 (1994).
Olson, L. J., Subramanian, R. & Edwards, W. D. Surgical pathology of pure aortic insufficiency: a study of 225 cases. Mayo Clin. Proc. 59, 835–841 (1984).
Fox, E. R. et al. Epidemiology of pure valvular regurgitation in the large middle-aged African American cohort of the Atherosclerosis Risk in Communities study. Am. Heart J. 154, 1229–1234 (2007).
Reid, C. L., Anton-Culver, H., Yunis, C. & Gardin, J. M. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am. J. Cardiol. 99, 830–834 (2007).
Singh, J. P. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am. J. Cardiol. 83, 897–902 (1999).
Palmieri, V. et al. Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: the Hypertension Genetic Epidemiology Network Study. Hypertension 37, 1229–1235 (2001).
Klein, A. L. et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J. Am. Soc. Echocardiogr. 3, 54–63 (1990).
Sahasakul, Y., Edwards, W. D., Naessens, J. M. & Tajik, A. J. Age-related changes in aortic and mitral valve thickness: implications for two-dimensional echocardiography based on an autopsy study of 200 normal human hearts. Am. J. Cardiol. 62, 424–430 (1988).
Yaghoubi, A. R. & Raeesi, K. Surgical pathology of excised heart valves in a referral hospital in Iran. RMJ 32, 70–72 (2007).
Yaghoubi, A. R. et al. A multi-center study of the pathologies of valvular heart diseases: 5 year analysis of more than 3400 patients in Iran. J. Cardiovasc. Thorac. Res. 2, 21–27 (2010).
Webb, R., Gentles, T., Stirling, J. & Wilson, N. Echocardiographic findings in a low risk population for rheumatic heart disease (RHD): implications for screening [Abstract; page 283]. XVIII Lancefield International Symposium [online], (2011).
Brand, A., Dollberg, S. & Keren, A. The prevalence of valvular regurgitation in children with structurally normal hearts: a color Doppler echocardiographic study. Am. Heart J. 123, 177–180 (1992).
Marcus, R. H. et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am. J. Cardiol. 63, 577–584 (1989).
Wilson, N. J. & Neutze, J. M. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int. J. Cardiol. 50, 1–6 (1995).
Choong, C. Y. et al. Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography. Am. Heart J. 117, 636–642 (1989).
Yoshida, K. et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 78, 840–847 (1988).
Akasaka TMD. et al. Age-related valvular regurgitation: a study by pulsed Doppler echocardiography. Circulation 76, 262–265 (1987).
Berger, M., Hecht, S. R., Van Tosh, A. & Lingam, U. Pulsed and continuous wave Doppler echocardiographic assessment of valvular regurgitation in normal subjects. J. Am. Coll. Cardiol. 13, 1540–1545 (1989).
Caldas, A. M. et al. The case for utilizing more strict quantitative Doppler echocardiographic criterions for diagnosis of subclinical rheumatic carditis. Cardiol. Young 17, 42–47 (2007).
Lanna, C. C. D., Tonelli, E., Barros, M. V. L., Goulart, E. M. A. & Mota, C. C. C. Subclinical rheumatic valvitis: a long-term follow-up. Cardiol. Young. 13, 431–438 (2003).
Carpentier, A. Cardiac valve surgery—the “French correction”. J. Thorac. Cardiovasc. Surg. 86, 323–337 (1983).
Anwar, A. M. et al. Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J. Am. Soc. Echocardiogr. 23, 13–22 (2010).
Umeda, T., Kuwako, K. & Machii, K. M-mode and cross-sectional echocardiographic evaluation of rheumatic mitral valve disease. Jpn. Circ. J. 43, 297–304 (1979).
Wann, L. S., Feigenbaum, H., Weyman, A. E. & Dillon, J. C. Cross-sectional echocardiographic detection of rheumatic mitral regurgitation. Am. J. Cardiol. 41, 1258–1263 (1978).
Naito, M., Morganroth, J., Mardelli, T. J., Chen, C. C. & Dreifus, L. S. Rheumatic mitral stenosis:cross-sectional echocardiographic analysis. Am. Heart J. 100, 34–40 (1980).
Kabukcu, M., Arslantas, E., Ates, I., Demircioglu, F. & Ersel, F. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation. Angiology 56, 159–163 (2005).
Reid, C. L., McKay, C. R., Chandraratna, P. A., Kawanishi, D. T. & Rahimtoola, S. H. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation 76, 628–636 (1987).
Zhou, L. Y. & Lu, K. Inflammatory valvular prolapse produced by acute rheumatic carditis: echocardiographic analysis of 66 cases of acute rheumatic carditis. Int. J. Cardiol. 58, 175–178 (1997).
Murala, J. S. K. & Kumar, A. S. Long-term results of cusp-level chordal shortening for anterior mitral leaflet prolapse. Tex. Heart Inst. J. 31, 246–250 (2004).
van der Bel-Kahn, J. M. D. & Becker, A. E. M. D. The surgical pathology of rheumatic and floppy mitral valves: distinctive morphologic features upon gross examination. Am. J. Surg. Pathol. 10, 282–292 (1986).
Nazarian, I. H. & Aryanpur, I. Pathology of chronic rheumatic mitral valvulitis in Iran and its surgical implications. Jpn. Heart J. 19, 1–11 (1979).
Leong, S. W. et al. Morphological findings in 192 surgically excised native mitral valves. Can. J. Cardiol. 22, 1055–1061 (2006).
Gorgulu, S. et al. Influence of different echocardiographic imaging modes on the assessment of anterior mitral leaflet thickness. J. Heart Valve Dis. 14, 204–208 (2005).
Hirata, K. et al. Pitfalls of echocardiographic measurement in tissue harmonic imaging: in vitro and in vivo study. J. Am. Soc. Echocardiogr. 15, 1038–1044 (2002).
Prior, D. L. et al. Impact of tissue harmonic imaging on the assessment of rheumatic mitral stenosis. Am. J. Cardiol. 86, 573–576 (2000).
Hawkins, K., Henry, J. S. & Krasuski, R. A. Tissue harmonic imaging in echocardiography: better valve imaging, but at what cost? Echocardiography 25, 119–123 (2008).
Webb, R., Lean, F., Zeng, I. & Wilson, N. Objective measurement of mitral valve thickness with and without rheumatic heart disease [Abstract]. 5th World congress of paediatric cardiology and cardiac surgery [online], (2009).
Weissman, N. J. et al. In vivo mitral valve morphology and motion in mitral valve prolapse. Am. J. Cardiol. 73, 1080–1088 (1994).
Freed, L. A. et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J. Am. Coll. Cardiol. 40, 1298–1304 (2002).
Uysal, S., Baysal, K., Balat, A. & Yukel, M. The relationship between mitral valve prolapse and acute rheumatic fever in pediatric patients. Jpn. Heart J. 33, 585–590 (1992).
Wu, M. H., Lue, H. C., Wang, J. K. & Wu, J. M. Implications of mitral valve prolapse in children with rheumatic mitral regurgitation. J. Am. Coll. Cardiol. 23, 1199–1203 (1994).
Gometza, B., al-Halees, Z., Shahid, M., Hatle, L. K. & Duran, C. M. Surgery for rheumatic mitral regurgitation in patients below twenty years of age. An analysis of failures. J. Heart Valve Dis. 5, 294–301 (1996).
Perier, P. Surgical repair of the prolapsing anterior leaflet with chordal shortening. Sem. Thorac. Cardiovasc. Surg. 16, 174–181 (2004).
Kumar, A. S., Talwar, S., Saxena, A., Singh, R. & Velayoudam, D. Results of mitral valve repair in rheumatic mitral regurgitation. Interact. Cardiovasc. Thorac. Surg. 5, 356 (2006).
Bernal, J. M., Rabasa, J. M., Vilchez, F. G., Cagigas, J. C. & Revuelta, J. M. Mitral valve repair in rheumatic disease. The flexible solution. Circulation 88, 1746–1753 (1993).
Stark, J., De Leval, M., Tsang, V. T. (Eds) Surgery for Congenital Heart Defects 3rd edn (John Wiley & Sons Ltd, London, 2006).
Barlow, J. B. Aspects of active rheumatic carditis. Aust. N. Z. J. Med. 22 (5 Suppl.), 592–600 (1992).
American College of Cardiology/American Heart Association Task Force on Practice Guidelines et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114, e84–e231 (2006).
Baird, C. W., Constantinos, C., Lansford, E. & Pigula, F. A. Mitral valve chordal rupture masquerades as endocarditis. Pediatr. Cardiol. 28, 297–299 (2007).
Jeresaty, R. M., Edwards, J. E. & Chawla, S. K. Mitral valve prolapse and ruptured chordae tendineae. Am. J. Cardiol. 55, 138–142 (1985).
Weidenbach, M., Brenner, R., Rantamaki, T. & Redel, D. A. Acute mitral regurgitation due to chordal rupture in a patient with neonatal Marfan syndrome caused by a deletion in exon 29 of the FBN1 gene. Pediatr. Cardiol. 20, 382–385 (1999).
Gabbay, U. & Yosefy, C. The underlying causes of chordae tendinae rupture: a systematic review. Int. J. Cardiol. 143, 113–118 (2010).
Cohen, G. I. et al. Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation. J. Am. Soc. Echocardiogr. 9, 508–515 (1996).
Myers, P. O. et al. Aortic valve repair by cusp extension for rheumatic aortic insufficiency in children: long-term results and impact of extension material. J. Thorac. Cardiovasc. Surg. 140, 836–844 (2010).
Bernal, J. M. et al. Repair of nonsevere rheumatic aortic valve disease during other valvular procedures: is it safe? J. Thorac. Cardiovasc. Surg. 115, 1130–1135 (1998).
Talwar, S., Saikrishna, C., Saxena, A. & Kumar, A. S. Aortic valve repair for rheumatic aortic valve disease. Ann. Thorac. Surg. 79, 1921–1925 (2005).
Bozbuga, N. et al. Midterm results of aortic valve repair with the pericardial cusp extension technique in rheumatic valve disease. Ann. Thorac. Surg. 77, 1272–1276 (2004).
Grinda, J. M. et al. Aortic cusp extension valvuloplasty for rheumatic aortic valve disease: midterm results. Ann. Thorac. Surg. 74, 438–443 (2002).
Tekumit, H. et al. Cusp shaving for concomitant mild to moderate rheumatic aortic insufficiency. J. Cardiac Surg. 25, 16–22 (2010).
Sashida, Y. et al. Ethnic differences in aortic valve thickness and related clinical factors. Am. Heart J. 159, 698–704 (2010).
Shapiro, L. M., Thwaites, B., Westgate, C. & Donaldson, R. Prevalence and clinical significance of aortic valve prolapse. Br. Heart J. 54, 179–183 (1985).
Bhaya, M., Beniwal, R., Panwar, S. & Panwar, R. B. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 28, 929–933 (2011).
Carapetis, J. R., Brown, A., Wilson, N. J. & Edwards, K. N. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med. J. Aust. 186, 581–586 (2007).
Council of Europe Committee of Ministers. Recommendation no. R(94)11 of the Committee of Ministers to the Member Sates on screening as a tool of preventative medicine. Council of Europe [online] (1994).
McDonald, M., Brown, A., Noonan, S. & Carapetis, J. R. Preventing recurrent rheumatic fever: the role of register based programmes. Heart 91, 1131–1133 (2005).
Galderisi, M. et al. Improved cardiovascular diagnostic accuracy by pocket size imaging device in non-cardiologic outpatients: the NaUSiCa (Naples Ultrasound Stethoscope in Cardiology) study. Cardiovasc. Ultrasound 8, 51 (2010).
Sicari, R. et al. The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography. Eur. J. Echocardiogr. 12, 85–87 (2011).
Acknowledgements
We acknowledge the support of RHDAustralia and Heart Association of Thailand in coordinating the investigators' meeting. B. Reményi's research position was funded by research scholarships from the National Heart Foundation of New Zealand and the Lowitja Institute of Australia. N. Wilson was funded part time by the Green Lane Research and Education Fund in 2010. L. Zühlke is supported by the NIH through the international clinical scholars and fellow program (R24 TW007988). Project grants were received from the Medtronic Foundation for the investigators' meeting and from the Green Lane Research and Education Fund for the website development.
Author information
Authors and Affiliations
Contributions
B. Reményi wrote the article. All authors researched data for the article, substantially contributed to discussion of the content, and reviewed/edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Concise summary of the 2012 World Heart Federation criteria for the echocardiographic diagnosis of rheumatic heart disease (PDF 116 kb)
Rights and permissions
About this article
Cite this article
Reményi, B., Wilson, N., Steer, A. et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev Cardiol 9, 297–309 (2012). https://doi.org/10.1038/nrcardio.2012.7
Published:
Issue date:
DOI: https://doi.org/10.1038/nrcardio.2012.7
This article is cited by
-
Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes
Drugs in R&D (2024)
-
Current Clinical Profile of Acute Rheumatic Fever and Recurrent Acute Rheumatic Fever in Pakistan
Pediatric Cardiology (2024)
-
Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study
Italian Journal of Pediatrics (2024)
-
2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease
Nature Reviews Cardiology (2024)
-
Left ventricular remodelling in rheumatic heart disease – trends over time and implications for follow-up in childhood
BMC Cardiovascular Disorders (2023)


